openPR Logo
Press release

CGMS Market predicted to reach USD 15.66 billion by 2030 with a CAGR of 22.7%

10-27-2021 06:43 PM CET | Health & Medicine

Press release from: Next Move Strategy Consulting

CGMS Market predicted to reach USD 15.66 billion by 2030 with

The Global CGMS Market size is estimated to be USD 1.65 billion in 2019 and is predicted to reach USD 15.66 billion by 2030 with a CAGR of 22.7% from 2020-2030.

CGMS is also known as continuous glucose monitoring system which is used for the continuous monitoring of glucose in diabetic patient. CGMS constant monitor the glucose level in case of increase and decrease in the glucose level above and below limits alert the patient. It also helps in the reduction in complications related to diabetes and it offer various benefits above glucose monitors in intensive care.

Access Full Description of this report at:-

https://www.nextmsc.com/report/cgms-market

Top Companies: Dexcom Inc., Medtronic plc., Abbott Laboratories, Ypsomed AG., Roche Diagnostics, Insulet Corporation, Sensonic Corporation, Novo Nordisk, Bayer AG, and Animas Corporation and others.

Market Dynamics and Trends

The increase in healthcare facilities and infrastructure coupled with increased prevalence of diabetes over the forecast period is expected to drive the growth of market. Furthermore, increase in intensive care and home care coupled with increase in wearable devices and technological advancement is expected to further propel the growth of CGMS market.

The other factor driving the growth of the market include increase in geriatric population and increase in chronic disorder which led to the development of diabetes in , changing lifestyle and others. However, lack of proper reimbursement policies and high cost o wearable devices are expected to impede the market growth over the forecast period. Increase in research and development and technological advancement in the CGMS are expected to create ample opportunities in the market.

Request sample copy of this report at:-

https://www.nextmsc.com/CGMS-Market/request-sample

Market Segmentations and Scope of the Study:

The global CGMS market share is analyzed on the basis of component, end user, and geography. On the basis of component, the market is segmented into Sensors, Transmitters & Receivers, and Integrated Insulin Pumps. On the basis of end users, the market is divided into Diagnostics/Clinics, ICUs, and Home Healthcare. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America represents the developed markets and anticipated to hold the major market share over the forecast period. The attributed factors include increased prevalence of diabetes, increase in intensive care coupled with increased awareness among people and technological advancement are expected to contribute the market growth.

Asia Pacific is expected to develop at a significant rate over the forecast period owing to the presence of emerging economies coupled with increase in geriatric population and increase accessibility to healthcare facilities are further expected to augment the growth of CGMS market.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CGMS Market predicted to reach USD 15.66 billion by 2030 with a CAGR of 22.7% here

News-ID: 2444897 • Views:

More Releases from Next Move Strategy Consulting

Acne Medication Market Set for Exponential Growth with a Projected 3.2% CAGR by 2030
Acne Medication Market Set for Exponential Growth with a Projected 3.2% CAGR by …
Introduction: According to the Next Move Strategy Consulting, the Global Acne Medication Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 3.2% from 2024 to 2030. The acne medication market is experiencing a transformative surge, driven by the increasing demand for effective solutions to address skincare concerns globally. As individuals prioritize skincare and beauty, the acne medication market emerges as a key player in providing innovative, targeted
Unleashing the Potential of the Hemodialysis Market for Unprecedented Growth with a CAGR of 3.60% by 2030
Unleashing the Potential of the Hemodialysis Market for Unprecedented Growth wit …
According to the Next Move Strategy Consulting, the Global Hemodialysis Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 3.60% from 2024 to 2030. In recent years, the global healthcare landscape has witnessed a significant surge in demand for advanced renal care solutions, with the hemodialysis market emerging as a pivotal player in addressing the evolving needs of patients grappling with kidney-related issues. Projections indicate that
Managed Mobility Services Market Accelerates Towards USD 133.90 Billion Valuation by 2030, Propelled by a Remarkable CAGR of 31.1%
Managed Mobility Services Market Accelerates Towards USD 133.90 Billion Valuatio …
In a groundbreaking revelation, industry experts at Next Move Strategy Consulting unveil a compelling trajectory for the managed mobility services market, foreseeing an exceptional valuation of USD 133.90 billion by 2030. This robust ascent is underpinned by an extraordinary CAGR of 31.1%, signifying the pivotal role managed mobility services play in reshaping the digital landscape and empowering businesses with unparalleled mobility solutions. Introduction: Positioned as a linchpin in the broader landscape of
The Infant Phototherapy Device Market Set for Remarkable Growth with a Projected CAGR of 4.0% by 2030
The Infant Phototherapy Device Market Set for Remarkable Growth with a Projected …
Introduction: According to the Next Move Strategy Consulting, the Global Infant Phototherapy Device Market size is anticipated to reflect a Compound Annual Growth Rate (CAGR) of 4.0% from 2024 to 2030. The global infant phototherapy device market is poised for unprecedented growth, driven by the increasing demand for advanced neonatal care solutions and a growing focus on improving infant health outcomes. This comprehensive analysis delves into the key drivers, market segmentation,

All 5 Releases


More Releases for CGMS

01-07-2022 | Health & Medicine
Nextmsc
CGMS Market Competitive Analysis and Pandemic Impact Analysis of Demand 2022-203 …
The Global CGMS Market size is estimated to be USD 1.65 billion in 2019 and is predicted to reach USD 15.66 billion by 2030 with a CAGR of 22.7% from 2020-2030. CGMS is also known as continuous glucose monitoring system which is used for the continuous monitoring of glucose in diabetic patient. CGMS constant monitor the glucose level in case of increase and decrease in the glucose level above and below
Continuous Glucose Monitoring System (CGMS) Market 2021 to 2027 - Industry Share …
As per the new study published by Data Library Research, titled, “CGMS Market by type, application, end use, and region: industry forecast and market potential analysis, 2021-2027,” the global market is rising at a considerable rate and is expected to maintain its growth rate during the forecast period. The study elaborates growth rate of the CGMS market supported and analysed after exhaustive and reliable company profile analysis. The report offers an
Continuous Glucose Monitoring Systems (CGMS) Market in U.S. Like to See Extensiv …
U.S. Continuous Glucose Monitoring Systems (CGMS) Market report it provides a vital recent industry data which covers in U.S. market situation along with future scenario for industry around the U.S. It also consists of major data along with forecasts of a U.S. market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "U.S. Continuous Glucose Monitoring Systems (CGMS) Market by
Continuous Glucose Monitoring Systems (CGMS) Market Comprehensive Study by Leadi …
According to the "Continuous Glucose Monitoring System (CGMS) Markets: Global Opportunity Analysis and Industry Forecasts, 2017-2023" published by Allied Market Research, by component, demographic and end user, the market is $ 894 million In 2016, it is expected to reach $ 4,921 million by 2024 and is expected to grow at an average annual rate of 22.9% from 2018 to 2024. The Continuous Glucose Monitoring System (CGMS) market has emerged as
Continuous Glucose Monitoring Systems (CGMS) Market | Top Worldwide Key Players …
Continuous Glucose Monitoring Systems (CGMS) Market growing at a CAGR of 22.9%, anticipated to reach $4,921 million by 2024. The continuous glucose monitoring systems (CGMS) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. Replacement/repeat sales of components such as sensors drive the growth of the CGMS market.Continuous glucose monitoring systems are mainly used by patients suffering from hypo and hyperglycemic conditions. Rise in
Continuous Glucose Monitoring Systems (CGMS) Market Expected to Reach $4,921 Mil …
Continuous Glucose Monitoring Systems (CGMS) Market by Components, Demographics, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% from 2018 to 2024. Access Full Summary at : https://www.alliedmarketresearch.com/global-continuous-glucose-monitoring-systems-market The continuous glucose monitoring systems (CGMS) market has emerged as a promising diabetes management tool for monitoring all types of